Conmed to buy sports surgery firm Bionx
This article was originally published in Clinica
Executive Summary
Conmed is continuing its buying spree with the acquisition of Bionx Implants, which develops polymer implants for sports medicine and other applications. It will pay $4.35 per Bionx share for a total of $48m.